Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Advanced Breast Cancer
NCT00075413Phase 2Withdrawn
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Nov 2002
- Primary completion
- Jul 2005
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of arsenic trioxide in breast cancer, sponsored by The University of Texas Medical Branch at Galveston. Planned start Nov 2002; status: withdrawn.
02
Drugs
arsenic trioxide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00075413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075413.